These results suggest that ALDH1A inhibition may be efficacious in certain types of IBD, similar to other existing treatments, and that IL-10 may be important for the WIN 18,446-mediated attenuation of colitis observed in Mdr1a−/− and Smad3−/− mice. This evidence concerns the gene SMAD3 and inflammatory bowel disease.